503a retatrutide ⚠️ Before you consider using retatrutide, know the facts. has not completed the FDA approval process, there is no official assessment confirming its safety or quality. The risks are real: 🚫 🔬 Retatrutide (Retta) BUD from

While no standardized FDA-mandated taper protocol exists for semaglutide discontinuation, a common clinical approach is to reduce the dose by one step (e.g., from 1 mg to 0.5 mg) for approximately four weeks before stopping entirely

MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study

This is one of the most important facts in the entire comparison, because it means every ranking of the two is cross-trial inference, not a controlled result

Reconstituted: refrigerated between 2-8C, use within 28 days